Company ProfilePremium

Aspinwall and Company Limited

Company Profile Analysis

Tickers: ASPINWALL.NS, 533030.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aspinwall and Company Limited - Company showcase

Year Founded & Workforce

1867

711 Employees

Aspinwall and Company Limited logo

Aspinwall and Company Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aspinwall and Company Limited Overview

Aspinwall and Company is one of the oldest surviving commercial houses on India's Malabar Coast. It is a 159-year-old, family-controlled, diversified micro-cap run by members of the erstwhile Royal Family of Travancore, who have held control since the early 1970s. The company operates four modest but distinct businesses. The first is port-centric logistics and customs brokerage across southern and western India. The second is the procurement, curing and export of specialty Indian coffees, notably Monsooned Malabar, mainly to European roasters. The third is a natural-rubber estate of roughly 2,200 acres in Malappuram, Kerala. The fourth is a small coir and natural-fibre manufacturing operation. Revenue reached INR 417 crore in FY2026, up 24% year on year. Margins, however, are thin and volatile: operating margin has stayed in a 3–8% band for five years, and net margin was about 3%. The investment case therefore rests less on growth than on three things: a conservative balance sheet, an unbroken dividend record, and a share price below book value.


The company's own description

The FY2025-26 Directors' Report describes Aspinwall as a diversified business entity. It names five activities: logistics services, coffee processing and trading, rubber plantations, and the manufacture and trading of natural fibre products and mattresses. Screener's summary of the FY2026 Annual Report adds commercial real-estate leasing of the company's "Aspinwall House" premises as a further activity. The Directors' Report says the company is working to use its facilities more fully to raise revenue from them. Morningstar's profile, drawn from filings, states that the reportable segments are Logistics, Coffee, Plantation and Others.

Independent characterization

Aspinwall is best understood as a working-capital-intensive agri-commodity exporter combined with an asset-light trade-services business, held together by a family holding structure. It is not a single integrated value chain. The two main businesses, Coffee and Logistics, produced about 81% of FY2026 revenue (CRISIL describes the pair as "nearly 80%"). They have different economics:

Coffee: is a merchant-processor model. Aspinwall buys green coffee, mainly from Karnataka and Kerala growers and traders. It then cures, grades, "monsoons" and exports it. Profit is a processing-and-trading spread, and it is exposed to two things: ICE coffee futures and domestic procurement prices. Profitability also depends heavily on inventory, because CRISIL notes a processing and sales cycle of 6–9 months.

Logistics: is a fee-based service model. The company acts as customs house agent, liner and ship agent, handles bulk cargo, provides stevedoring, freight forwarding, air cargo (IATA-accredited), warehousing, and project or over-dimensional cargo handling. Margins are steady at about 8–10% of segment revenue. Volumes follow India's EXIM trade cycle and port-specific bulk flows, particularly at Mangaluru.

Plantation: is a natural-rubber estate. It produces centrifuged latex and technically specified natural rubber, and also makes Esophageal Varices Ligation (EVL) bands, a medical consumable. Earnings follow rubber prices and the age profile of the trees.

Others: consists mainly of natural fibre (coir mats, mattings, rugs, runners, mattresses and coir geotextiles through a subsidiary), healthcare products and minor trading. This segment has been at or below breakeven for most of the last five years.

Revenue model mix

Revenue typeBusinessesApproximate share of FY2026 revenueBasis
Product sales (commodity and manufactured goods)Coffee, Plantation (rubber, latex, EVL bands), Natural fibre, HealthcareAbout 62%Zonebourse segment data: Coffee + Plantation + Others = INR 256.7 crore out of 416.7 crore
Service feesLogistics (CHA, freight forwarding, ship agency, stevedoring, warehousing), pharma logistics (SFS)About 38%Logistics segment INR 160 crore
Rental/leasingAspinwall House premisesNot separately disclosed (immaterial; included in other income or Others)Directors' Report FY2026 mentions leasing optimisation
Subscription/licensing—0%—

Value-chain position, customers and end-markets

BusinessValue-chain positionCustomer typesEnd-markets
CoffeeMid-stream: procurement, curing, monsooning, grading, exportSpecialty and commercial roasters, green-coffee importersExports, about 85% to Switzerland, Germany, Italy, the UK and Scandinavia; the balance to Australia, the USA, Japan and Russia (company disclosure cited by TradingView research); plus domestic sales
LogisticsIntermediary service provider at ports, ICDs and airportsExporters, importers, shipping lines, project cargo owners, pharma and clinical-trial sponsors (via SFS Pharma Logistics)Indian EXIM trade, bulk commodities, project cargo
PlantationUpstream grower and primary processorTyre and rubber-goods manufacturers, latex users, hospitals and distributors (EVL bands)Domestic natural-rubber market; medical devices
Natural fibreManufacturer and exporterRetailers and importers of floor coverings; domestic mattress buyers; infrastructure and erosion-control buyers (geotextiles)The USA, Europe and India

Strategy

Stated strategic themes (FY2025-26 Annual Report, paraphrased)

Aspinwall publishes no investor-day material or formal medium-term strategy. The strategic signals in the FY2026 Directors' Report and Management Discussion & Analysis are:

  1. Plantation productivity: a long-term programme to extend the economic life of rubber trees from 25 to 32 years, which the company says is showing positive early results.

  2. Asset monetisation: using the Aspinwall House facilities more fully to raise leasing revenue.

  3. Logistics branch performance: improvement at individual branches, with Chennai cited.

  4. Natural Fibre defence: coping with weaker domestic mattress demand and US tariff-driven price cuts. No restructuring has been announced.

  5. Cost vigilance: the company flags risk from Middle East conflict inflating raw-material, packaging and logistics costs.

  6. Subsidiary momentum: the SFS Pharma Logistics discussion in the Directors' Report states confidence that positive business momentum will continue into FY2026-27.

Initiative register (last 24 months)

InitiativeDate / statusTypeTarget or metric disclosedSource
Rubber tree life extension (25 to 32 years)Ongoing; early results positive (FY2026 AR)ProductivityNone quantifiedDirectors' Report FY2026
Aspinwall House leasing optimisationOngoingAsset monetisationNone quantifiedDirectors' Report FY2026
Enhancement of bank working-capital lines (INR 126.5 crore to INR 153.5 crore)September 2026FinancingSupports inventory-heavy coffee growthCRISIL 28-Sep-2026
Healthcare products (Aspinwall Healthcare)Since 2020; ongoingNew businessNone disclosedCRISIL
EVL band manufacturingOngoingProduct diversificationNone disclosedIIFL
Transformation programmes, cost programmes with targetsNone announced———
ESG or sustainability commitmentsNone publicly announced———

Medium-term guidance

Not publicly disclosed. Management does not issue financial guidance. CRISIL's forward view, which is not company guidance, expects annual net cash accrual of INR 9–11 crore and no significant debt-funded capex.

Products & Services

Pricing models are not publicly disclosed for any product. The company publishes no product-level revenue. Launch years are given only where disclosed.

Logistics segment

OfferingDescription and capabilitiesTarget customerLaunch/notesSource
Customs House Agency (CHA)Customs clearance and documentation at major ports, ICDs and airportsExporters and importersLong-standing; network of about 9–11 branchesWright Research; IIFL
Liner services and ship agencyAgency for shipping lines and vessel calls; port agency, spare-parts handling, bunker and fuel supply coordinationShipping lines and ship ownersShipping heritage since 1867Wright Research; MagicPort
Bulk cargo handling and stevedoringLoading and unloading of bulk commodities, notably at Mangaluru portBulk commodity shippersMangaluru bulk cargo volume is tracked as a KPI (figure not public)Screener insights
Air cargoIATA-accredited cargo agencyTime-sensitive exporters—Tradomate summary
Freight forwardingInternational sea and air freight forwardingShippers—Wright Research
Project and over-dimensional cargo (ODC)Customs clearance, handling and transport of heavy-lift and ODC consignmentsEPC contractors and project ownersHandled "major projects" (no list disclosed)IIFL summary
WarehousingStorage and handlingShippers and traders—Wright Research
Pharma and clinical-trial logistics (SFS Pharma Logistics)Specialised logistics for clinical-trial shipments and pharmaceutical productsPharma companies and CROsEntity incorporated 2011CRISIL
Marine services (Malabar Coast Marine Services)Logistics and marine-related servicesShipping and port usersEntity incorporated 1990CRISIL

Coffee segment

OfferingDescriptionTarget customerNotesSource
Monsooned Malabar AAArabica beans exposed to monsoon winds on the Malabar coast, which gives low acidity and a heavy body; a geographical-indication coffee of IndiaSpecialty roasters (Europe)Flagship specialty gradeWright Research
Monsooned Robusta AARobusta beans processed by monsooningEspresso blenders and roastersFlagship specialty gradeWright Research
Other green coffee grades (arabica and robusta)Purchasing, curing, grading and export of commercial and specialty green coffeeImporters and roastersGrade list not disclosedMorningstar
Coffee curing and processing worksMangaluru (Kulshekar) curing and processing facilityCaptiveProcessing and sales cycle of 6–9 months per CRISILCRISIL
Export sales office's-Hertogenbosch, NetherlandsEuropean buyers—Morningstar; IIFL

Plantation segment

OfferingDescriptionTarget customerNotesSource
Natural rubber estateAbout 2,200 acres of rubber plantations in Malappuram district, Kerala—Strategy to extend economic tree life from 25 to 32 years is showing early positive results (FY2026 Directors' Report)Simply Wall St; Directors' Report
Centrifuged latexConcentrated latex for dipped goodsLatex-goods makers—IIFL; Simply Wall St
Technically specified natural rubber (ISNR/TSR)Graded block rubberTyre and rubber-goods makers—IIFL
EVL bands / multi-band ligatorMedical consumable for endoscopic ligation of esophageal varices, made at the plantation divisionHospitals and medical distributorsDiversification "of late"; launch year not disclosedIIFL; PL India

Others segment (Natural Fibre, Healthcare, miscellaneous)

OfferingDescriptionTarget customerNotesSource
Coir entrance and corridor matsHandloom and power-loom coir matsRetailers and importers (USA, Europe)Pollachi (and historically Alleppey)Wright Research
Mattings, carpets, rugs, runnersNatural-fibre floor coverings; in-house design centre and custom designs to buyer specificationsImporters and retail chains—IIFL
Mesh mattingsCoir mesh productsCommercial buyers—Wright Research
Coir mattressesNatural-fibre mattressesIndian consumersSharp fall in domestic sales in FY2026FY2026 Directors' Report
Coir geotextiles (Aspinwall Geotech)Erosion control and soil conservation productsInfrastructure contractors and government agencies—CRISIL
Medical products (Aspinwall Healthcare)Manufacturing and trading of medical products, accessories and equipmentHealthcare buyersSince 2020CRISIL
Virgin coconut oilPremium virgin coconut oil tradingConsumers and retailersLaunched 2020Pocketful; Tradomate
Premises leasing (Aspinwall House)Commercial leasing of company premisesCorporate tenantsRevenue not separately disclosedScreener key points; Directors' Report

Financial Narrative

Basis. Consolidated figures. Source: Screener.in, compiled from company filings and accessed October 2026. FY2025 and FY2026 revenue and PAT were cross-checked with CRISIL and ScanX (company filing summaries). Screener rounds to whole crore, so ratios computed from it carry rounding error of about ±1 crore. Precise FY2025 and FY2026 figures are used where available.

Income statement

Notes. EPS is the same on a basic and diluted basis because there are no dilutive instruments. FY2024 and FY2026 DPS are confirmed from NSE filings (60% of INR 10 face value in FY2024, INR 6.50 in FY2026). FY2025 DPS of INR 6.50 is confirmed by TipRanks/TradingView as the last paid dividend. FY2022 and FY2023 DPS are derived from Screener's payout ratios (31% and 16%) and are consistent with INR 6. Gross profit is not reported in a consistent multi-year form. Simply Wall St shows a trailing gross profit of INR 150 crore on revenue of INR 380 crore (TTM to December 2025), which implies a gross margin of about 39%. Gross margin is therefore excluded from the chartable tables.

Margins and growth (analyst-computed)

Revenue CAGR. The four-year CAGR from FY2022 to FY2026 is about 12.5% (INR 260 crore to INR 417 crore). The five-year CAGR from FY2021 (INR 253 crore) to FY2026 is about 10.5%, matching Screener's reported 5-year sales growth of 10.5%. Profit CAGR is much weaker. Screener reports compounded profit growth of 4% over five years and minus 21% over three years, because FY2023 profit was inflated by INR 21 crore of other income.

Quarterly trajectory (consolidated)

Source: Screener.in quarterly consolidated data. Q1 FY2027 cross-checked with Business Standard/Capital Market (6 August 2026) and the NSE board outcome of 5 August 2026, which reported a consolidated loss of INR 70 lakh and a standalone loss of INR 134 lakh.

Seasonality. The first quarter (April–June) has been weak in each of the last three years: Q1 FY2024 OPM was 1.0%, Q1 FY2026 was minus 2.0%, and Q1 FY2027 was 1.0%. The second half (October–March) is consistently the strongest. The coffee export calendar and rubber tapping seasonality are the likely drivers. Investors should not annualize first-quarter results.

Balance sheet

Notes and items not disclosed in the data accessed:

Cash and equivalents: Year-end balances were not available in the aggregator data used. CRISIL states that average cash and bank balances were about INR 11 crore over the 12 months to August 2026. Craft.co reports cash of INR 16.7 crore at Q2 FY2026. Net debt is therefore estimated, not reported: about INR 65–70 crore at 31 March 2026 (borrowings of INR 79 crore less roughly INR 10–15 crore of cash).

Short-term versus long-term debt: CRISIL's facility annexure shows the rated borrowings are working-capital lines: export packing credit, cash credit and working capital demand loans. CRISIL also states nil term-debt obligations over the medium term. Debt is therefore essentially all short-term working-capital finance.

Goodwill and intangibles: Not separately disclosed; believed immaterial given that the subsidiaries were formed rather than acquired.

Working capital: Screener working-capital days were 84, 60, 68, 70 and 81 for FY2022–FY2026. CRISIL puts gross current assets at about 194 days and inventory at about 141 days at 31 March 2026, on its own methodology.

Net worth: CRISIL's figure of INR 201 crore at 31 March 2026 matches Screener. Book value per share is INR 257.

Cash flow

Notes. Screener reports its own "free cash flow" series (15, 42, -5, -39, -20). It differs from the analyst computation above because Screener uses a different capex definition. Both series show the same direction. Dividends declared are derived from DPS multiplied by 7,818,288 shares. Cash dividends paid fall in the following fiscal year. No buyback has been authorized in the period.

Commentary on trends, inflections and drivers

Revenue. Top-line growth accelerated in FY2026 (+24%) after two flat-to-modest years. The drivers were a 36% rise in Coffee revenue and a 20% rise in Logistics. Coffee revenue in a merchant model follows the price of the commodity as much as volume. International coffee prices were exceptionally high through 2024–2025. Part of the growth is therefore probably price pass-through rather than real volume expansion. Management has not disclosed a volume and price split.

Profitability. The decline in profitability is the central problem. Operating margin fell from about 7% in FY2022–FY2023 to 3.3% in FY2024, recovered to 5.7% in FY2025, and slipped back to 4.4% in FY2026, despite record revenue. Net profit in FY2026 (INR 13.16 crore) was lower than in FY2025 (INR 14.53 crore) on 24% more revenue. CRISIL notes that operating profitability stayed in a 3–8% band over the five fiscals to 2026. Its downgrade trigger is EBITDA margin staying below 3.5%, which FY2026 cleared by less than one percentage point. Other income is volatile and material: INR 21 crore in FY2023, and INR 6.5 crore in Q2 FY2026 alone. It has repeatedly decided whether a quarter shows a profit or a loss.

Balance sheet and cash. In FY2025 the business turned from cash-generative to cash-absorbing. Operating cash flow was minus INR 35 crore in FY2025 and minus INR 22 crore in FY2026, as coffee inventory and receivables grew. Borrowings tripled from INR 23 crore to INR 79 crore over two years and interest cost rose from about INR 4 crore to INR 7 crore. Leverage is still conservative in absolute terms (debt to equity of 0.39x) and CRISIL considers liquidity adequate. Average fund-based limit utilisation was about 63%, and cash-credit utilisation only about 20%, over the 12 months to August 2026. The enlargement of rated bank lines from INR 126.5 crore to INR 153.5 crore in September 2026 suggests management expects inventory financing to grow further.

Returns. Excluding the FY2023 other-income spike, ROE has stayed between 6% and 8%. That is well below India's cost of equity (usually taken as about 12–14%). This explains why the stock trades below book value.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityIncorporatedOwnershipActivitySegment mappingSource

Aspinwall and Company Limited (parent)

1920

Listed

Logistics, Coffee, Plantation, Natural Fibre, leasing

All

Filings

Malabar Coast Marine Services Pvt Ltd

1990100%

Logistics and marine-related services

Logistics

CRISIL

Aspinwall Geotech Ltd

1994100%

Coir geotextiles for environmental engineering and soil conservation

Others (natural fibre)

CRISIL

SFS Pharma Logistics Pvt Ltd

2011100%

Specialised pharma and clinical-trial shipment logistics (offices in Mumbai and Hyderabad)

Logistics

CRISIL; MagicPort

Aspinwall Healthcare Pvt Ltd

2020100%

Manufacturing and trading of medical and healthcare products

Others

CRISIL

Segment revenue (INR Cr)

Segment revenue (INR Cr)FY2022FY2023FY2024FY2025FY2026

Coffee (INR Cr)

101.0109.0120.0131.0178.0

Logistics (INR Cr)

130.0151.0127.0133.0160.0

Plantation (INR Cr)

15.426.236.256.063.3

Others incl. Natural Fibre (INR Cr)

13.48.211.515.815.4

Total segment revenue (INR Cr)

259.8294.4294.7335.8416.7

Revenue by Segment

Segment result (INR Cr)FY2022FY2023FY2024FY2025FY2026

Coffee (INR Cr)

14.619.25.915.712.7

Logistics (INR Cr)

12.714.513.010.412.4

Plantation (INR Cr)

4.00.54.15.04.4

Others incl. Natural Fibre (INR Cr)

-3.1-1.50.30.4-0.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment margin (%)

Segment margin (%)FY2022FY2023FY2024FY2025FY2026

Coffee margin (%)

14.517.64.912.07.1

Logistics margin (%)

9.89.610.27.87.8

Plantation margin (%)

26.11.911.28.87.0

Others margin (%)

-22.8-18.52.82.8-1.9

Segment YoY revenue growth (%)

Segment YoY revenue growth (%)FY2023FY2024FY2025FY2026

Coffee growth (%)

7.910.19.235.9

Logistics growth (%)

16.2-15.94.720.3

Plantation growth (%)

70.138.254.713.0

Others growth (%)

-38.840.237.4-2.5

Contribution to total revenue (%)

Contribution to total revenue (%)FY2022FY2023FY2024FY2025

Coffee share (%)

38.937.040.739.0

Logistics share (%)

50.051.343.139.6

Plantation share (%)

5.98.912.316.7

Others share (%)

5.22.83.94.7

Segment assets (INR Cr)

Segment assets (INR Cr)FY2022FY2023FY2024FY2025FY2026

Coffee assets (INR Cr)

88.168.686.6133.0165.0

Logistics assets (INR Cr)

61.860.870.783.578.5

Plantation assets (INR Cr)

22.725.023.628.826.8

Others assets (INR Cr)

23.923.225.727.830.9

Unallocated assets (INR Cr)

43.267.844.038.632.0

Segment capex (INR Cr)

Segment capex (INR Cr)FY2022FY2023FY2024FY2025FY2026

Coffee capex (INR Cr)

0.340.153.410.491.54

Logistics capex (INR Cr)

1.410.885.361.243.18

Plantation capex (INR Cr)

1.321.991.751.531.05

Others capex (INR Cr)

2.241.590.432.871.87

Unallocated capex (INR Cr)

0.590.081.891.341.34

Income statement (INR Cr)

Income statement (INR Cr)FY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

260295296335.96417.15

Total operating expenses (INR Cr)

241273286317399

EBITDA excl. other income (INR Cr)

1921101918

Other income (INR Cr)

7219610

Depreciation (INR Cr)

45556

EBIT incl. other income (INR Cr)

22381420.222.0

Finance cost (INR Cr)

3244.076.84

Profit before tax (INR Cr)

19361016.115.2

Effective tax rate (%)

1820-121013

Net profit (INR Cr)

15291114.5313.16

EPS basic and diluted (INR)

19.5336.5213.6618.5816.83

Dividend per share (INR)

6.06.06.06.56.5

Margins and growth (%)

Margins and growth (%)FY2022FY2023FY2024FY2025FY2026

Revenue growth YoY (%)

2.813.50.313.624.2

EBITDA (operating) margin (%)

7.37.13.35.74.4

EBIT margin incl. other income (%)

8.512.94.76.05.3

Pre-tax margin (%)

7.312.23.44.83.6

Net margin (%)

5.89.83.74.33.2

Income Statement and Per-Share Data

Quarterly metric (INR Cr)Q1FY2025Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Revenue (INR Cr)

82.9874.0089.7789.2190.0083.19113.66130.30113.18

EBITDA excl. other income (INR Cr)

4.264.676.223.72-1.780.0910.179.131.09

Other income (INR Cr)

2.181.201.451.501.096.500.332.161.61

Finance cost (INR Cr)

0.630.770.761.911.961.941.831.111.74

Profit before tax (INR Cr)

4.583.835.642.05-3.973.277.198.71-0.54

Net profit (INR Cr)

3.673.784.822.26-3.272.807.626.01-0.70

EPS (INR)

4.694.836.172.89-4.183.589.757.69-0.90

Balance Sheet

Balance sheet (INR Cr)FY2022FY2023FY2024FY2025FY2026

Equity share capital (INR Cr)

88888

Reserves (INR Cr)

146169175185193

Total equity / net worth (INR Cr)

154177183193201

Total borrowings (INR Cr)

2417236979

Other liabilities (INR Cr)

6252445053

Total assets (INR Cr)

240246251312333

Net fixed assets (INR Cr)

8281878489

Capital work in progress (INR Cr)

11132

Investments (INR Cr)

22111

Other assets incl. inventory, receivables, cash (INR Cr)

155161162224241

Cash flow (INR Cr)

Cash flow (INR Cr)FY2022FY2023FY2024FY2025FY2026

Cash from operations (INR Cr)

16354-35-22

Cash from investing (INR Cr)

39-7-2320

Cash from financing (INR Cr)

-17-13-137-3

Net cash flow (INR Cr)

231-4-21-5

Capex, sum of segment capex (INR Cr)

5.94.712.87.59.0

Free cash flow, CFO minus capex (INR Cr)

10.130.3-8.8-42.5-31.0

Dividend declared for the year, DPS x shares (INR Cr)

4.74.74.75.15.1

Share buybacks (INR Cr)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE on average equity, analyst-computed (%)

10.117.56.17.76.7

ROA on average assets, analyst-computed (%)

6.311.94.45.24.1

ROCE, Screener (%)

1012796

ROIC, 25% normalized tax, analyst-computed (%)

9.315.35.36.56.1

Debt to equity (x)

0.160.100.130.360.39

Gross debt to EBITDA (x)

1.30.82.33.64.4

Interest coverage, EBIT to finance cost, analyst-computed (x)

7.319.03.55.03.2

Asset turnover, revenue to average assets (x)

1.101.211.191.191.29

Debtor days

3929323744

Inventory days

393280206307272

Payable days

6849283330

Cash conversion cycle (days)

364260210312287

Dividend payout (%)

3116443539

Geographic revenue (INR Cr)

Geographic revenue (INR Cr)FY2022FY2023FY2024FY2025FY2026

India (INR Cr)

170.0201.0193.0225.0280.0

Europe (INR Cr)

72.284.592.198.8119.0

Americas incl. Canada and South America (INR Cr)

10.83.55.26.610.8

Rest of world (INR Cr)

7.05.15.25.38.2

Geographic growth YoY (%)

Geographic growth YoY (%)FY2023FY2024FY2025FY2026

India growth (%)

18.2-4.016.624.4

Europe growth (%)

17.09.07.320.4

Americas growth (%)

-67.648.626.963.6

Rest of world growth (%)

-27.12.01.954.7

Geographic share of revenue (%)

Geographic share of revenue (%)FY2022FY2023FY2024FY2025FY2026

India share (%)

65.468.365.567.067.0

Europe share (%)

27.828.731.329.428.5

Americas share (%)

4.21.21.82.02.6

Rest of world share (%)

2.71.71.81.62.0

Capital Markets

MeasureValueSource

Price (19-Oct-2026)

INR 236

Screener

Price (8-Oct-2026)

INR 245.89; year to date minus 5.82%

Zonebourse

1-year return

About minus 8%

Screener

3-year CAGR

About minus 1%

Screener

5-year CAGR

About 6%

Screener

52-week high / low

INR 300 / INR 200

Screener

All-time high

INR 579.50 (27-Dec-2017)

TradingView

All-time low

INR 71.40 (23-Mar-2020)

TradingView

Valuation Multiples

MultipleAspinwallBasis

P/E, TTM (x)

11.7

TTM consolidated PAT of INR 15.73 crore (Q2 FY2026 to Q1 FY2027). Screener displays 15.5x, apparently on a different earnings basis

P/E, FY2026 (x)

14.0

FY2026 EPS of INR 16.83

P/B (x)

0.92

Book value of INR 257 per share

EV/EBITDA, TTM (x)

About 12.3

EV of about INR 252 crore (market cap 184 + debt 79 − cash of about 11); TTM EBITDA INR 20.5 crore

EV/Sales, TTM (x)

About 0.57

TTM revenue of INR 440 crore

Dividend yield (%)

2.75

INR 6.50 / INR 236

Dividend metric

Dividend metricFY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

6.06.06.06.56.5

Dividend payout ratio (%)

3116443539

Total dividend declared (INR Cr)

4.74.74.75.15.1

Analyst Conclusions

Guidance and consensus

Management guidance: none issued. The Directors' Report gives qualitative optimism only for SFS Pharma Logistics.

Consensus: no sell-side coverage. Simply Wall St reports zero analysts and insufficient data for price targets.

CRISIL's forward view: net cash accrual of INR 9–11 crore a year, no significant debt-funded capex, and a stable outlook.

Bull case

  1. Coffee spread normalization. Coffee earned 12–18% segment margins in FY2022, FY2023 and FY2025. If FY2026 revenue (INR 178 crore) is held at a 12% margin, segment profit would be about INR 21 crore, against INR 12.7 crore reported. That would add roughly INR 6 crore to after-tax profit, a significant amount relative to a market cap of INR 184 crore.

  2. Asset backing. The stock trades at 0.92x book (INR 201 crore of equity) and about 0.57x TTM sales, with a 2.75% dividend yield. There is no term debt. Downside appears well cushioned.

  3. Growth plus diversification. The second half of FY2026 showed what the business can earn. Q3 and Q4 together produced INR 13.6 crore of PAT on INR 244 crore of revenue. Revenue grew 24% in FY2026 and 26% in Q1 FY2027.

Bear case

  1. Value trap economics. ROE has stayed between 6% and 8% for three years. Each additional rupee of coffee revenue requires a large inventory investment. Operating cash flow was negative in both FY2025 and FY2026 despite record revenue.

  2. Margin fragility. FY2026 EBITDA margin of 4.4% and Q1 FY2027 of 0.96% sit close to CRISIL's 3.5% downgrade trigger. Commodity and currency exposure is unhedged.

  3. Structural headwinds and governance stasis. The Others segment is pressured by the US tariff and weak mattress demand. There is no investor communication, no institutional ownership and a shrinking retail base. These factors remove the usual catalysts for re-rating.

Catalysts and monitorables (next 12 months)

Expected timingCatalyst / monitorableWhat to watch
Early November 2026Q2 FY2027 results (trading window closed 1-Oct-2026)Coffee margin; other-income dependence; borrowings
February 2027Q3 FY2027 resultsSeasonal peak; whether OPM exceeds 8%
May 2027FY2027 audited results and dividendFull-year OCF sign; DPS maintained at INR 6.50 or more
OngoingICE arabica and robusta prices; Indian rubber pricesSpread and segment margin direction
OngoingUS–India tariff developmentsNatural-fibre export pricing
OngoingCRISIL surveillanceRating action if margin stays below 3.5%
OngoingLeasing income from Aspinwall House; SFS Pharma growthContribution to Others and Logistics

Analyst verdict

Aspinwall and Company is a durable but under-earning business. It survived 159 years, a change of ownership in the 1970s and a COVID-era share price collapse to INR 71. It enters FY2027 with record revenue (INR 417 crore), an unbroken dividend record, nil term debt and an investment-grade domestic rating (CRISIL BBB/Stable). Those facts set a firm floor. At 0.92x book, roughly 12x trailing earnings and a 2.75% yield, the market is not paying for any growth.

That floor comes with a low ceiling, however. The FY2026 numbers show the core tension clearly. Revenue rose 24%, while net profit fell 9%, operating cash flow was minus INR 22 crore, borrowings reached INR 79 crore and interest coverage slid to about 3x. The coffee franchise, now the largest segment, converts commodity inflation into revenue but not into proportionate profit. It also absorbs balance-sheet capacity. Logistics is a steady INR 10–14 crore earner but is not growing its margin. Plantation has re-rated with rubber prices and is now plateauing. Natural fibre is a drag. With ROE of 6–8% and no hedging policy, the business destroys value relative to its cost of equity in an average year.

Change would require one of three things. The first is a sustained recovery in coffee spreads toward historical 12%-plus margins. The second is management choosing to release working capital and return cash, or to monetise assets such as the Aspinwall House leasing. The third is a step-up in disclosure that brings in institutional interest. None of these is signalled in current filings. The 64.46% promoter holding has been unchanged for at least a decade and the board composition is stable, so strategic inflection is likely to come slowly, if at all.

Verdict: a low-risk, low-return, asset-backed micro-cap. It suits patient, income-oriented holders who can tolerate illiquidity. It is unlikely to re-rate without margin and cash-flow evidence. The two items most likely to move the stock in the next twelve months are coffee segment margin and the sign of operating cash flow.


Source register (principal documents)

#SourceTypeDate accessed / dated
1NSE board outcome: FY2024 audited results and dividendPrimary filing29-May-2024
2NSE board outcome: Q2 FY2026 resultsPrimary filing3-Nov-2025
3NSE board outcome: Q3 FY2026 resultsPrimary filing6-Feb-2026
4NSE board outcome: Q1 FY2027 resultsPrimary filing5-Aug-2026
5NSE intimation: director re-appointmentsPrimary filing1-Aug-2023
6Annual Report FY2025-26, Directors' Report (via IIFL/Goodreturns reproduction)Primary (reproduced)Filed 30-Jun-2026
7CRISIL Ratings rationaleRating agency28-Sep-2026
8CRISIL credit bulletinRating agency8-Oct-2026
9Screener.in consolidated financials, shareholding and announcementsAggregator (filing-derived)19/20-Oct-2026
10Zonebourse/MarketScreener segment and geography dataAggregator (S&P/FactSet-derived)8-Oct-2026
11ScanX: FY2026 results, AGM, non-encumbranceNews (filing summaries)May–Jul 2026
12Business Standard / Capital Market: Q1 FY2027 resultsNews6-Aug-2026
13Simply Wall St, Morningstar, TipRanks, TradingView, StockAnalysisAggregators2025–2026
14CCL Products, Harrisons Malayalam, Tiger Logistics, Patel Integrated FY2026 results coveragePeer data (news)May–Aug 2026
15ICCI Cochin, IIFL, PL India, Pocketful company historiesHistorical backgroundVarious
16The News Minute, The Art Newspaper, Onmanorama, News Arena India (Aspinwall House / Biennale)Media2022–2026

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenure / key datesBackgroundAgeCompensationSource

Rama Varma (DIN 00031890)

Managing Director (Executive; promoter group)

Whole-Time Director from 1-Aug-2005; MD from 1-Apr-2007; re-appointed for 3 years from 1-Aug-2026 (special resolution passed with 99.9996% of votes cast)

B.Sc.; Director of Varma Exports Ltd; former Independent Director of Nirlon Ltd (2006–2019)

——

ScanX; Simply Wall St; MarketScreener

Thalasseril Raghavankutty (T. R.) Radhakrishnan

Executive Director and Chief Financial Officer

Remuneration approved at 106th AGM (23-Jul-2026)

Long-serving finance head (details not disclosed)

——

ScanX

Mahadev Lakshminarayanan

Chairman and Independent Director

Independent Director from about 2017; Chairman from 2023 (Simply Wall St shows about 7 years on the board)

——

About INR 1.66 million (aggregator figure, year unspecified)

Blinkx; Simply Wall St

Chemprol Raja Raja Varma (C. R. R. Varma) (DIN 00031924)

Non-Executive Director (promoter)

Over four decades with the company as MD and then Non-Executive Director; re-appointed in 2023; director in three subsidiaries

Promoter family

——

NSE intimation 1-Aug-2023

Avittam Thirunal Adithya Varma

Non-Executive Director (promoter)

Appointed 17-Aug-2017

Commerce graduate

Born 15-Apr-1971 (55)

—

Blinkx; MarketScreener

Company Secretary

Company Secretary and Compliance Officer

—————

“—” = not publicly disclosed.

Board & Management Changes

DateChangeContext

1-Aug-2023

Rama Varma re-appointed MD; C. R. R. Varma re-appointed Non-Executive Director

Routine renewal (NSE intimation)

27-May-2026

Board recommends re-appointment of Rama Varma as MD for 3 years from 1-Aug-2026

FY2026 board meeting (ScanX)

23-Jul-2026

AGM approves the MD re-appointment and the ED & CFO remuneration

All six resolutions passed (ScanX)

Shareholding Trend

Shareholder category (% of equity)Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Promoters (%)

64.4664.4664.4664.4664.4664.4664.4664.46

FIIs (%)

0.000.050.010.000.000.000.000.00

Public incl. DIIs (%)

35.5435.4935.5335.5435.5435.5435.5435.54

Number of shareholders

5,0114,8234,7424,6914,6114,6764,5264,405

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning versus AspinwallSource / note

Coffee

CCL Products (India) Ltd

Listed; instant coffee and green coffee

Far larger (FY2026 revenue INR 4,457 crore); value-added instant coffee rather than specialty green export

CCL FY2026 results

Coffee

Tata Consumer Products (plantation coffee, after the merger of Tata Coffee)

Listed conglomerate

Integrated grower, processor and brand owner; much larger scale

General industry knowledge

Coffee

ofi (Olam Food Ingredients) India

Global merchant

Global origination and financing advantages

General industry knowledge

Coffee

Neumann Kaffee Gruppe / Ned Commodities, Sucafina, Volcafe (ED&F Man)

Global green-coffee merchants with India sourcing

Buy competitively at origin; strong hedging ability that Aspinwall lacks

General industry knowledge

Coffee

Allanasons and other Indian coffee exporters

Private exporters

Similar exporter model

General industry knowledge

Logistics

Tiger Logistics (India) Ltd

Listed freight forwarder

Larger (FY2026 revenue INR 572.82 crore); pure-play forwarding

Tiger Logistics FY2026 results

Logistics

Patel Integrated Logistics Ltd

Listed multimodal and air cargo

Comparable scale (FY2026 total income INR 357.25 crore)

Patel FY2026 results

Logistics

Allcargo / ECU Worldwide, Transworld, JM Baxi

National and global logistics and ship agency

Much larger networks

General industry knowledge

Logistics

Local CHAs and ship agents at Kochi, Mangaluru and Chennai

Fragmented private players

Aspinwall competes on legacy relationships

CRISIL (long track record)

Plantation (rubber)

Harrisons Malayalam Ltd

Listed tea and rubber planter (Kerala)

Larger and diversified planter (FY2026 revenue INR 539.08 crore)

Harrisons FY2026 results

Plantation (rubber)

Malayalam Plantations, AVT, Rubber Board-linked estates, smallholders

Planters

Most Indian rubber comes from smallholders, so the market is a price-taker market

General industry knowledge

Natural fibre

Kerala and Tamil Nadu coir exporters; Sheela Foam (Kurlon) in coir mattresses

Private and listed

Aspinwall is a small niche participant

General industry knowledge

Peer Comparison FY2026

Metric (FY2026)AspinwallCCL ProductsHarrisons MalayalamTiger Logistics

Revenue from operations (INR Cr)

417.154,457.37539.08572.82

Revenue growth YoY (%)

24.243.54.96.8

EBITDA / operating profit (INR Cr)

18741.3748.73—

EBITDA margin (%)

4.416.69.0—

Net profit (INR Cr)

13.16388.1129.1521.52

Net margin (%)

3.28.75.43.8

Recent Developments

There were no layoffs, litigation, regulatory actions, restructurings or guidance revisions in the period, according to the filings reviewed.

Company Snapshot

$48.2M

Revenue

711

Employees

1867

Founded

Logistics, India

Headquarters

SWOT Analysis

Strengths

  • Conservative balance sheet. Debt to equity was 0.39x and net worth INR 201 crore at FY2026. CRISIL describes the financial risk profile as healthy and puts total outside liabilities to tangible net worth at 0.63x (CRISIL, 28-Sep-2026).
  • Diversified earnings. Four segments with different cycles kept operating margin within 3–8% over five years, even during the FY2024 logistics slump (logistics revenue minus 16%) (CRISIL; Zonebourse).
  • Long, uninterrupted dividend record. INR 6 or more per share in each of FY2022–FY2026, with payout of 31–44% (Screener; NSE filings).
  • Logistics earnings stability. Segment profit of INR 10.4–14.5 crore every year from FY2022 to FY2026 (Zonebourse segment data).
  • Specialty coffee niche. Flagship Monsooned Malabar AA and Monsooned Robusta AA, with about 85% of exports going to quality-sensitive European markets (company disclosures cited by TradingView research; Wright Research).
  • Adequate liquidity headroom. Cash-credit utilisation of about 20%, overall fund-based limit utilisation of about 63%, and limits enhanced to INR 153.5 crore (CRISIL).
  • Stable, unpledged promoter control. 64.46% holding, unchanged for at least a decade, with no encumbrance in FY2026 (Screener; ScanX).

Weaknesses

  • Thin and falling margins. FY2026 EBITDA margin of 4.4% and net margin of 3.2%. Net profit fell 9% on 24% revenue growth (Screener; CRISIL).
  • Negative cash generation. Operating cash flow of minus INR 35 crore in FY2025 and minus INR 22 crore in FY2026. Analyst-computed FCF was minus INR 42.5 crore and minus INR 31.0 crore (Screener; segment capex).
  • Very heavy working capital. Cash conversion cycle of 287 days and inventory of 272 days in FY2026 (Screener). CRISIL puts gross current assets at about 194 days.
  • Sub-par returns. Consolidated ROE of 6.7% and ROCE of 6% in FY2026, both below a reasonable cost of equity (analyst calculation; Screener).
  • Persistently loss-making or breakeven Others segment. Segment result of minus INR 3.1 crore (FY2022), minus INR 1.5 crore (FY2023) and minus INR 0.3 crore (FY2026) (Zonebourse).
  • Earnings dependence on other income. INR 21 crore in FY2023 (58% of PBT). In Q2 FY2026, INR 6.5 crore of other income turned an operating breakeven into a profit (Screener).
  • Minimal investor disclosure. No investor presentations, no earnings calls, and no analyst coverage. Valuation is likely to stay depressed as a result.

Opportunities

  • Coffee price cycle. If green-coffee prices stabilise, procurement spreads could return toward the 12–18% segment margins of FY2022, FY2023 and FY2025 (Zonebourse history).
  • Plantation productivity. Extending tree life from 25 to 32 years would defer replanting capex and lift yield per hectare (FY2026 Directors' Report).
  • Pharma logistics. SFS Pharma Logistics has positive momentum guided into FY2027 and sits in a higher-value logistics niche (Directors' Report).
  • Leasing income. Fuller use of the Aspinwall House premises was flagged by management as a revenue lever (Directors' Report; Screener key points).
  • Re-rating from a discount. The stock trades at 0.92x book (INR 236 versus book value of INR 257). Any improvement in disclosure or returns could narrow the discount (Screener).
  • European specialty demand. Europe revenue grew 20% in FY2026 to INR 119 crore, the fastest rate in five years (Zonebourse).

Threats

  • US tariff regime. A 50% US import tariff has already forced price cuts on Natural Fibre exports (FY2026 Directors' Report).
  • Commodity volatility without hedging. CRISIL explicitly flags the absence of significant commodity and foreign-exchange hedging (CRISIL, 28-Sep-2026).
  • Ratings headroom is narrow. CRISIL's downgrade trigger is EBITDA margin staying below 3.5%. FY2026 came in at 4.4%, and Q1 FY2027 at 0.96% (CRISIL; Screener).
  • Geopolitical cost inflation. The Middle East conflict is flagged as a risk to raw-material, packaging and logistics costs (FY2026 Directors' Report).
  • Rising interest burden. Finance cost rose from about INR 4 crore (FY2025) to about INR 6.8 crore (FY2026). Interest coverage fell to 3.2x (Screener; CRISIL reports 2.97x).
  • Consumer demand weakness in mattresses. The FY2026 Directors' Report cites a sharp fall in domestic sales.
  • Thinning shareholder base and illiquidity. Shareholders fell from 5,192 (September 2024) to 4,405 (September 2026) (Screener).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
13-May-2025CRISIL reaffirms BBB/Stable and A3+ CRISIL rating historyCredit stability confirmed
18-May-2025Media report the Kerala government is close to buying Aspinwall House (Fort Kochi) from DLF News Arena IndiaThird-party heritage asset; brand relevance only
May 2025FY2025 results: revenue INR 336 crore (+14%), PAT INR 14.53 crore (+36%), EPS INR 18.59 Simply Wall St; CRISILRecovery year after weak FY2024
8-Jul-2025FY2024-25 Annual Report filed with NSE NSE annual-report archiveDisclosure
Jul/Aug 2025FY2025 dividend of INR 6.50 per share paid TipRanks; TradingViewDividend raised from INR 6
Aug-2025 onwardUS 50% import tariff on Indian goods hits Natural Fibre export pricing FY2026 Directors' ReportMargin erosion in Others segment
4-Aug-2025Q1 FY2026 results: revenue INR 90.0 crore, consolidated net loss INR 3.27 crore (EPS minus INR 4.18) Screener; TipRanksWorst quarter in the period; operating loss
3-Nov-2025Q2 FY2026 results: revenue INR 83.19 crore, PAT INR 2.80 crore, helped by INR 6.5 crore of other income NSE board outcome; ScreenerProfit dependent on other income
5-Dec-2025Share price at INR 231; market cap about INR 181 crore Simply Wall StStock near 52-week lows
12-Dec-2025Kochi-Muziris Biennale (6th edition) opens using part of Aspinwall House (Fort Kochi) The Art Newspaper; OnmanoramaThird-party; brand visibility
6-Feb-2026Q3 FY2026 results: revenue INR 113.66 crore (+27% YoY), PAT INR 7.62 crore (+58%), EPS INR 9.75 NSE board outcome; Kotak NeoBest quarter of FY2026; OPM of 8.95%
16-Mar-2026CRISIL reaffirms BBB/Stable and A3+Credit stability
6-Apr-2026Promoters declare no encumbrance on shares for FY2026 ScanXGovernance comfort
27-May-2026FY2026 audited results approved: revenue INR 417.15 crore (+24%), PAT INR 13.16 crore (minus 9%); unmodified audit opinion ScanX; CRISILRecord revenue, lower profit
27-May-2026Board recommends INR 6.50 dividend and MD re-appointment from 1-Aug-2026 for 3 years ScanXDividend maintained; leadership continuity
28-May-2026Q4 FY2026: revenue INR 130.30 crore (+46% YoY), PAT INR 6.01 crore (+166% YoY) Business Standard (via HDFC Sec); IndMoneyStrong second-half finish
30-Jun-2026FY2025-26 Annual Report filed with NSE NSE annual-report archiveDisclosure
2-Jul-2026Record date of 16-Jul-2026 fixed for AGM voting and dividend ScanXCorporate action
15/16-Jul-2026Annual dividend announced, payable 22-Aug-2026 MarketScreenerShareholder return
23-Jul-2026106th AGM (by video conference): all six resolutions passed, including MD re-appointment, ED & CFO remuneration and cost-auditor remuneration ScanXGovernance continuity
25-Jul-2026AGM voting results disclosed under SEBI LODR Regulation 44 Screener/NSEDisclosure
5-Aug-2026Q1 FY2027: revenue INR 113.18 crore (+25.8% YoY), consolidated loss INR 0.70 crore (versus loss of INR 3.27 crore), standalone loss INR 1.34 crore NSE board outcome; Business StandardSmaller seasonal Q1 loss; OPM of 0.96%
10-Aug-2026Q1 FY2027 results newspaper publication Screener/NSEDisclosure
22-Aug-2026FY2026 dividend of INR 6.50 paid MarketScreenerFifth consecutive year of at least INR 6
28-Sep-2026CRISIL reaffirms BBB/Stable and A3+; rated facilities enhanced to INR 153.5 crore from INR 126.5 croreMore inventory financing headroom
29-Sep-2026Trading window closed from 1-Oct-2026 ahead of Q2 FY2027 results Screener/NSEResults due (likely early November 2026)
30-Sep-2026Shareholding: promoters 64.46%; shareholders 4,405, down from 4,526 in June ScreenerThinning retail base
7-Oct-2026Regulation 74(5) depository certificate filed for the September quarter Screener/NSERoutine compliance
8-Oct-2026CRISIL credit bulletin updates lender-wise facilities (Federal Bank EPC now INR 15 crore plus INR 20 crore; HDFC EPC INR 30 crore at A3+)Lender mix update
19-Oct-2026Share price INR 236; market cap about INR 184 crore; 1-year return about minus 8% ScreenerTrades at about 0.92x book

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 2,600 Mn in FY2022 to INR 4,171.5 Mn in FY2026.
Aspinwall and Company Limited — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations2,6002,9502,9603,359.64,171.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.